Cell line · CVCL_1751
TE 381.T
Cancer cell line, Homo sapiens. Embryonal rhabdomyosarcoma. 3 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. TE 381.T. Cell lines, record CVCL_1751. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1751
On this page
Cell line
As Cellosaurus gives it.
- Name
- TE 381.T
- Accession
- CVCL_1751
- RRID
- RRID:CVCL_1751
- Synonyms
- TE-381-T, TE381T, RD114-B
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 7Y
- Category
- Cancer cell line
- Diseases
- Embryonal rhabdomyosarcoma (NCIt C8971); Embryonal rhabdomyosarcoma (ORDO Orphanet_99757)
- Derived from
- Pelvis, muscle (in situ)
- Parent
- RD (CVCL_1649)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Wrongly indicated by ATCC to originate from a 7 week old female donor. Older product sheets of ATCC correctly indicated it originates from a 7 year old female. |
Source Cellosaurus
Papers3
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| High-Risk Rhabdomyosarcomas Feature a Convergent Cell State. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas. | Mol Oncol | 2022 | Its Methods give the RRID and name the line | PubMed | |
| A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. | Cancer Res | 2010 | Cellosaurus cites it | PubMed |
Relatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | RD | CVCL_1649 |
Source Cell lines
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| ATCC | CRL-7763 |
Source ATCC
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1751
GET https://conductscience.org/api/cell-lines/v1/CVCL_1751/problems